Intellia Therapeutics - 53 Year Dividend History | NTLA

Historical dividend payout and yield for Intellia Therapeutics (NTLA) since 1971. The current TTM dividend payout for Intellia Therapeutics (NTLA) as of April 12, 2024 is $0.00. The current dividend yield for Intellia Therapeutics as of April 12, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.332B $0.036B
Intellia Therapeutics is a leading clinical-stage genome editing company focused on developing CRISPR/Cas9-based therapeutics. The company is pursuing two primary approaches to fully realize the transformative potential of CRISPR/Cas9 in vivo programs that use intravenously administered CRISPR as the therapy and ex vivo programs that use CRISPR to create the therapy by using engineered human cells.?
Stock Name Country Market Cap PE Ratio